Faculty of Chinese Medicine, State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Taipa, Macao, Macao.
Department of Endocrinology, Zhuhai Hospital of Integrated Traditional Chinese and Western Medicine, Zhuhai, China.
Curr Drug Targets. 2021;22(3):336-346. doi: 10.2174/1389450121666200324151530.
With the recognition of the important role of gut microbiota in both health and disease progression, attempts to modulate its composition, as well as its co-metabolism with the organism, have attracted special attention. Abundant studies have demonstrated that dysfunction or imbalance of gut microbiota is closely related to disease progression, including endocrine diseases, neurodegenerative diseases, tumors, cardiovascular diseases, etc. Herbal medicines have been applied to prevent and treat diseases worldwide for hundreds of years. Although the underlying mechanism seems to be complex, one of the important ones is through modulating gut microbiota. In this review, co-metabolism between herbal medicines and microbiota, as well as the potential pathways are summarized from most recent published papers.
随着人们认识到肠道微生物群在健康和疾病进展中的重要作用,试图调节其组成以及与机体的共代谢已引起特别关注。大量研究表明,肠道微生物群的功能障碍或失衡与疾病进展密切相关,包括内分泌疾病、神经退行性疾病、肿瘤、心血管疾病等。草药已在全球范围内应用于预防和治疗疾病数百年。尽管潜在的机制似乎很复杂,但其中一个重要的机制是通过调节肠道微生物群。本文从最近发表的论文中总结了草药与微生物群之间的共代谢及其潜在途径。